person · Reporting owner

ZOLLARS ROBERT

Disclosed activity across 4 companies

Tapewire entity: 79380
SEC CIK: 0001231089

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Five9, Inc.FIVN · Entity 4346	Director	May 21, 2025	May 22, 2025
VOCERA COMMUNICATIONS, INC.VCRA · Entity 12917	Director	July 18, 2017	July 19, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Five9, Inc.

Report date May 21, 2025 · Filed May 22, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	76,371	Reported balance After 2025-05-21 transaction · row 1 1 source row Row 1 · 2025-05-21 · Grant · Acquired 7,840 · Balance 76,371
Common StockSEC Table I · non-derivative	IndirectBy ZoCo L.P. (Family Partnership)	1,784	Reported balance Holding disclosure · report date 2025-05-21 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 1,784

VOCERA COMMUNICATIONS, INC.

Report date July 18, 2017 · Filed July 19, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy ZoCo, L.P.	90,901	Last balance in matching sequence After 2017-07-18 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2017-07-18 · Exercise / conversion · Acquired 57,925 · Balance 148,826 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F4: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Row 2 · 2017-07-18 · Sale · Disposed 57,925 · Balance 90,901 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2: Represents the aggregate of sales effected on the same day at different prices. F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.52 to $26.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F4: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.74 · Expires 2017-07-30	IndirectBy ZoCo L.P.	0	Reported balance After 2017-07-18 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-07-18 · Exercise / conversion · Disposed 57,925 · Balance 0 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F5: The option fully vested on April 16, 2012. F4: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein.
Common StockSEC Table I · non-derivative	Direct	42,748	Reported balance Holding disclosure · report date 2017-07-18 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 42,748

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017.

F2: Represents the aggregate of sales effected on the same day at different prices.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.52 to $26.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein.

F5: The option fully vested on April 16, 2012.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Change Healthcare Inc.

Report date October 03, 2022 · Filed October 05, 2022

Section 16 reporting ended · disclosed 2022-10-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2022-10-03 transaction · row 1 1 source row Row 1 · 2022-10-03 · Disposition to issuer · Disposed 40,706 · Balance 0 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2027-10-17	Direct	Reported balance After 2022-10-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-10-03 · Disposition to issuer · Disposed 26,544 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F3: These options are fully vested.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2028-05-25	Direct	Reported balance After 2022-10-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-10-03 · Disposition to issuer · Disposed 5,056 · Balance 0 F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F3: These options are fully vested.

Filing footnotes · ownership attribution and instrument terms

F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax.

F2: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units.

F3: These options are fully vested.

F4: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.

VWR Corp

Report date November 21, 2017 · Filed November 22, 2017

Section 16 reporting ended · disclosed 2017-11-22. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common stockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-11-21 transaction · row 1 1 source row Row 1 · 2017-11-21 · Disposition to issuer · Disposed 7,617 · Balance 0 F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest.
Director stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.00 · Expires 2021-10-01	Direct	0	Reported balance After 2017-11-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2017-11-21 · Disposition to issuer · Disposed 22,617 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date.

Filing footnotes · ownership attribution and instrument terms

F1: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest.

F2: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 21, 2025 Filed May 22, 2025 21:25 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	7,840	$0.00	$0.00	Disclosure SEC source: 0001288847-25-000129 · wk-form4_1747949127.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,371 Read SEC document
May 14, 2024 Filed May 16, 2024 20:27 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	3,755	$0.00	$0.00	Disclosure SEC source: 0001288847-24-000073 · wk-form4_1715891240.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,531 Read SEC document
May 16, 2023 Filed May 18, 2023 20:52 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	3,669	$0.00	$0.00	Disclosure SEC source: 0001288847-23-000097 · wf-form4_168444311221863.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,776 Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:45 UTC	Five9, Inc. FIVN · Entity 4346	Exercise / conversionStock Option (right to buy) · Derivative	57,741	$0.00 Strike: $10.12	$0.00	Disclosure SEC source: 0001288847-22-000116 · wf-form4_166846230577577.xml · derivative · entry 3 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,741 shares Expires 2023-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option granted on December 13, 2013 is fully vested. Read SEC document
November 10, 2022 Filed Nov 14, 2022 21:45 UTC	Five9, Inc. FIVN · Entity 4346	Exercise / conversionCommon Stock	57,741	$10.12	$584,338.92	Disclosure SEC source: 0001288847-22-000116 · wf-form4_166846230577577.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:30 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	5,056	Not disclosed Strike: $18.99	Not disclosed	Disclosure SEC source: 0000899243-22-033002 · doc4.xml · derivative · entry 3 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,056 shares Expires 2028-05-25 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F3 · derivative.exercise_date: These options are fully vested. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:30 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerStock Option (right to buy) · Derivative	26,544	Not disclosed Strike: $18.99	Not disclosed	Disclosure SEC source: 0000899243-22-033002 · doc4.xml · derivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,544 shares Expires 2027-10-17 F4 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F3 · derivative.exercise_date: These options are fully vested. Read SEC document
October 03, 2022 Filed Oct 5, 2022 16:30 UTC	Change Healthcare Inc. CHNG · Entity 15437	Disposition to issuerCommon Stock	40,706	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-22-033002 · doc4.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. F2 · shares: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. F2 · price: At the Effective Time of the Merger, all deferred stock units of the Issuer automatically vested and were automatically converted into UnitedHealth Group deferred stock units calculated by taking the merger consideration of $25.75 per share of Common Stock and dividing it by the volume weighted average of the closing sale prices per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including settlement terms) as were applicable to the Issuer deferred stock units. Read SEC document
May 18, 2022 Filed May 20, 2022 21:55 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	2,132	$0.00	$0.00	Disclosure SEC source: 0001288847-22-000064 · wf-form4_165308372472798.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,366 Read SEC document
April 25, 2022 Filed Apr 27, 2022 17:05 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	7,658	$0.00	$0.00	Disclosure SEC source: 0001062993-22-010877 · form4.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,706 F1 · shares: Represents the grant of deferred stock units that vest on April 25, 2023. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document
June 22, 2021 Filed Jun 24, 2021 14:26 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	7,136	$0.00	$0.00	Disclosure SEC source: 0001062993-21-005914 · form4.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,048 F1 · shares: Represents the grant of deferred stock units that vests on June 22, 2022. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document
May 18, 2021 Filed May 20, 2021 23:47 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	3,407	$165.42	$563,585.94	Disclosure SEC source: 0001288847-21-000083 · wf-form4_162155444463222.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 1,784 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.14 to $165.60, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 12, 2021 Filed May 13, 2021 21:15 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	1,234	$0.00	$0.00	Disclosure SEC source: 0001288847-21-000075 · wf-form4_162094050436999.xml · nonDerivative · entry 5 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,018 Read SEC document
May 11, 2021 Filed May 13, 2021 21:15 UTC	Five9, Inc. FIVN · Entity 4346	Exercise / conversionStock Option (right to buy) · Derivative	29,759	$0.00 Strike: $10.12	$0.00	Disclosure SEC source: 0001288847-21-000075 · wf-form4_162094050436999.xml · derivative · entry 7 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,741 Underlying: Common Stock · 29,759 shares Expires 2023-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option granted on December 20, 2013 is fully vested. Read SEC document
May 11, 2021 Filed May 13, 2021 21:15 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	1,120	$169.35	$189,672.00	Disclosure SEC source: 0001288847-21-000075 · wf-form4_162094050436999.xml · nonDerivative · entry 4 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.91 to $169.67, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 11, 2021 Filed May 13, 2021 21:15 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	18,339	$168.12	$3,083,152.68	Disclosure SEC source: 0001288847-21-000075 · wf-form4_162094050436999.xml · nonDerivative · entry 3 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,904 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.90 to $168.90, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 11, 2021 Filed May 13, 2021 21:15 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	10,300	$167.45	$1,724,735.00	Disclosure SEC source: 0001288847-21-000075 · wf-form4_162094050436999.xml · nonDerivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,243 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.89 to $167.86, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 11, 2021 Filed May 13, 2021 21:15 UTC	Five9, Inc. FIVN · Entity 4346	Exercise / conversionCommon Stock	29,759	$10.12	$301,161.08	Disclosure SEC source: 0001288847-21-000075 · wf-form4_162094050436999.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 06, 2020 Filed Aug 10, 2020 20:09 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	5,344	$126.52	$676,122.88	Disclosure SEC source: 0001288847-20-000128 · wf-form4_159709017771538.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 3,407 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.51 to $126.99, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
June 17, 2020 Filed Jun 19, 2020 16:40 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	14,486	$0.00	$0.00	Disclosure SEC source: 0001062993-20-002927 · form4.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,912 F1 · shares: Represents the grant of deferred stock units that vests on June 17, 2021. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document
May 18, 2020 Filed May 20, 2020 20:53 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	1,784	$0.00	$0.00	Disclosure SEC source: 0001288847-20-000082 · wf-form4_159000799744445.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,784 Read SEC document
May 12, 2020 Filed May 14, 2020 22:18 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	800	$105.41	$84,328.00	Disclosure SEC source: 0001288847-20-000071 · wf-form4_158949471545430.xml · nonDerivative · entry 3 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 5,344 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.33 to $105.48, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 12, 2020 Filed May 14, 2020 22:18 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	1,500	$104.64	$156,960.00	Disclosure SEC source: 0001288847-20-000071 · wf-form4_158949471545430.xml · nonDerivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 6,144 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.08 to $105.00, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 12, 2020 Filed May 14, 2020 22:18 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	10,528	$103.29	$1,087,437.12	Disclosure SEC source: 0001288847-20-000071 · wf-form4_158949471545430.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 7,644 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.00 to $103.93, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
March 02, 2020 Filed Mar 3, 2020 21:04 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	8,000	$72.41	$579,280.00	Disclosure SEC source: 0001288847-20-000032 · wf-form4_158326945290342.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 18,172 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.15 to $73.13, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
August 20, 2019 Filed Aug 22, 2019 17:29 UTC	Change Healthcare Inc. CHNG · Entity 15437	GrantCommon Stock	11,426	$0.00	$0.00	Disclosure SEC source: 0000899243-19-022327 · doc4.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,426 F1 · shares: Represents the grant of deferred stock units that vests on August 1, 2020. The shares subject to the units will be issued to the Reporting Person after the Reporting Person's separation from service from the Issuer. Read SEC document
August 06, 2019 Filed Aug 7, 2019 20:24 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	25,000	$55.70	$1,392,500.00	Disclosure SEC source: 0001288847-19-000112 · wf-form4_156520948288938.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,407 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.56 to $55.92, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 28, 2019 Filed May 30, 2019 22:32 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	3,407	$0.00	$0.00	Disclosure SEC source: 0001288847-19-000081 · wf-form4_155925554310399.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,235 Read SEC document
February 22, 2019 Filed Feb 26, 2019 23:35 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	28,500	$52.93	$1,508,505.00	Disclosure SEC source: 0001288847-19-000032 · wf-form4_155122413151423.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,172 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.47 to $53.27, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
August 09, 2018 Filed Aug 10, 2018 20:57 UTC	Five9, Inc. FIVN · Entity 4346	SaleCommon Stock	10,000	$43.72	$437,200.00	Disclosure SEC source: 0001288847-18-000132 · wf-form4_153393463106801.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo L.P. (Family Partnership) Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.07 to $44.21, inclusive. The reporting person undertakes to provide Five9, Inc., any security holder of Five9, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
May 18, 2018 Filed May 22, 2018 00:13 UTC	Five9, Inc. FIVN · Entity 4346	GrantCommon Stock	5,344	$0.00	$0.00	Disclosure SEC source: 0001288847-18-000092 · wf-form4_152694799926830.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,672 Read SEC document
November 21, 2017 Filed Nov 22, 2017 18:38 UTC	VWR Corp VWR · Entity 171619	Disposition to issuerDirector stock option (right to buy) · Derivative	22,617	$12.25 Strike: $21.00	$277,058.25	Disclosure SEC source: 0000899243-17-027345 · doc4.xml · derivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 22,617 shares Expires 2021-10-01 F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each director stock option that was outstanding immediately prior to the Closing Date, whether or not exercisable or vested, was canceled and converted into the right to receive (i) an amount in cash determined by multiplying (A) the excess (if any) of $33.25 over the exercise price per share of Common Stock underlying such stock option by (B) the number of shares of Common Stock subject to such stock option immediately prior to the Closing Date. Read SEC document
November 21, 2017 Filed Nov 22, 2017 18:38 UTC	VWR Corp VWR · Entity 171619	Disposition to issuerCommon stock	7,617	$33.25	$253,265.25	Disclosure SEC source: 0000899243-17-027345 · doc4.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On May 4, 2017, VWR Corporation (the "Company") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Avantor, Inc. and Vail Acquisition Corp ("Merger Sub"), pursuant to which Merger Sub would merge (the "Merger") with and into the Company, with the Company continuing as the surviving corporation. The Merger became effective on November 21, 2017 (the "Closing Date"). Pursuant to the Merger Agreement, (i) each share of the Company's common stock, par value $0.01 ("Common Stock"), issued and outstanding prior to the Closing Date was cancelled and converted into the right to receive a cash payment equal to $33.25 and without interest and (ii) each restricted stock unit outstanding prior to the Closing Date was cancelled and converted into the vested right to receive a cash payment equal to $33.25 and without interest. Read SEC document
July 18, 2017 Filed Jul 19, 2017 21:31 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative	57,925	$0.00 Strike: $1.74	$0.00	Disclosure SEC source: 0001140361-17-028228 · doc1.xml · derivative · entry 4 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo L.P. Disclosed balance after: 0 Underlying: Common Stock · 57,925 shares Expires 2017-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F5 · derivative.exercise_date: The option fully vested on April 16, 2012. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
July 18, 2017 Filed Jul 19, 2017 21:31 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	SaleCommon Stock	57,925	$25.78	$1,493,173.27	Disclosure SEC source: 0001140361-17-028228 · doc1.xml · nonDerivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 90,901 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $25.52 to $26.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
July 18, 2017 Filed Jul 19, 2017 21:31 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionCommon Stock	57,925	$1.74	$100,789.50	Disclosure SEC source: 0001140361-17-028228 · doc1.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 148,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
July 05, 2017 Filed Jul 6, 2017 20:39 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative	62,000	$0.00 Strike: $1.74	$0.00	Disclosure SEC source: 0001140361-17-027401 · doc1.xml · derivative · entry 5 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo L.P. Disclosed balance after: 57,925 Underlying: Common Stock · 62,000 shares Expires 2017-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F6 · derivative.exercise_date: The option fully vested on April 16, 2012. F5 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
July 05, 2017 Filed Jul 6, 2017 20:39 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	SaleCommon Stock	58,202	$25.44	$1,480,658.88	Disclosure SEC source: 0001140361-17-027401 · doc1.xml · nonDerivative · entry 3 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 90,901 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.965 to $25.96 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F5 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
July 05, 2017 Filed Jul 6, 2017 20:39 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	SaleCommon Stock	3,798	$24.91	$94,614.26	Disclosure SEC source: 0001140361-17-027401 · doc1.xml · nonDerivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 149,103 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.8601 to $24.96 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F5 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
July 05, 2017 Filed Jul 6, 2017 20:39 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionCommon Stock	62,000	$1.74	$107,880.00	Disclosure SEC source: 0001140361-17-027401 · doc1.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 152,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F5 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
June 19, 2017 Filed Jun 19, 2017 20:32 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative	62,000	$0.00 Strike: $1.74	$0.00	Disclosure SEC source: 0001140361-17-025523 · doc1.xml · derivative · entry 4 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo L.P. Disclosed balance after: 119,925 Underlying: Common Stock · 62,000 shares Expires 2017-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F5 · derivative.exercise_date: The option fully vested on April 16, 2012. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
June 19, 2017 Filed Jun 19, 2017 20:32 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	SaleCommon Stock	62,000	$26.91	$1,668,134.80	Disclosure SEC source: 0001140361-17-025523 · doc1.xml · nonDerivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 90,901 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $26.59 to $27.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
June 19, 2017 Filed Jun 19, 2017 20:32 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionCommon Stock	62,000	$1.74	$107,880.00	Disclosure SEC source: 0001140361-17-025523 · doc1.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 152,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
June 05, 2017 Filed Jun 5, 2017 20:27 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative	62,000	$0.00 Strike: $1.74	$0.00	Disclosure SEC source: 0001140361-17-023870 · doc1.xml · derivative · entry 4 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo L.P. Disclosed balance after: 181,925 Underlying: Common Stock · 62,000 shares Expires 2017-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F5 · derivative.exercise_date: The option fully vested on April 16, 2012. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
June 05, 2017 Filed Jun 5, 2017 20:27 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	SaleCommon Stock	62,000	$26.69	$1,654,854.40	Disclosure SEC source: 0001140361-17-023870 · doc1.xml · nonDerivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 90,901 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $26.12 to $26.98 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
June 05, 2017 Filed Jun 5, 2017 20:27 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionCommon Stock	62,000	$1.74	$107,880.00	Disclosure SEC source: 0001140361-17-023870 · doc1.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 152,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
June 01, 2017 Filed Jun 2, 2017 21:39 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	GrantCommon Stock	5,285	$0.00	$0.00	Disclosure SEC source: 0001140361-17-023698 · doc1.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,748 F1 · shares: Represents a restricted stock unit award that vests in full on June 1, 2018. Read SEC document
May 18, 2017 Filed May 22, 2017 17:41 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative	62,000	$0.00 Strike: $1.74	$0.00	Disclosure SEC source: 0001140361-17-021781 · doc1.xml · derivative · entry 4 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo L.P. Disclosed balance after: 243,925 Underlying: Common Stock · 62,000 shares Expires 2017-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F5 · derivative.exercise_date: The option fully vested on April 16, 2012. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
May 18, 2017 Filed May 22, 2017 17:41 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	SaleCommon Stock	62,000	$24.98	$1,549,063.80	Disclosure SEC source: 0001140361-17-021781 · doc1.xml · nonDerivative · entry 2 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 90,901 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.73 to $25.12 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document
May 18, 2017 Filed May 22, 2017 17:41 UTC	VOCERA COMMUNICATIONS, INC. VCRA · Entity 12917	Exercise / conversionCommon Stock	62,000	$1.74	$107,880.00	Disclosure SEC source: 0001140361-17-021781 · doc1.xml · nonDerivative · entry 1 ZOLLARS ROBERT · CIK 0001231089 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By ZoCo, L.P. Disclosed balance after: 152,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2017. F4 · ownership.nature: Mr. Zollars and his wife are general partners and their children are limited partners. Mr. Zollars disclaims beneficial ownership of shares held by ZoCo L.P. except to the extent of his pecuniary interest therein. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.